Ignite Creation Date:
2025-12-24 @ 12:41 PM
Ignite Modification Date:
2026-01-14 @ 7:48 PM
Study NCT ID:
NCT03012061
Status:
COMPLETED
Last Update Posted:
2020-10-28
First Post:
2017-01-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma
Sponsor:
GlaxoSmithKline
Organization: